Topical Chemical Solution for Non-Acne Scar Treatment

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for treating hypertrophic and keloid scars are ineffective, and surgical excision is costly with high regeneration rates, while existing non-surgical treatments are inadequate for raised scars.

Innovation Solution

An alcohol-based topical chemical solution containing 1,3-dihydroxybenzene, alpha-hydroxy acids, and beta-hydroxy acids is applied to the scar tissue, optionally enhanced by microneedling or dry needling to increase penetration, promoting collagen reorganization and uniformity with the surrounding skin.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If surgical excision is used to remove scars, then the scar is removed, but the cost is high and regeneration occurs in over 50% of cases

Engineering Contradiction:
Improvescar removal effectivenessVSAvoidtreatment cost
Core Design Contradiction:
ReliabilityVSEase of manufacture

Solution Approach 1:

The patent replaces the mechanical surgical excision system with a chemical formulation system. The topical chemical solution containing alpha-hydroxy acids, beta-hydroxy acids, and 1,3-dihydroxybenzene chemically acts on scar tissue to soften and reorganize collagen fibers, eliminating the need for mechanical cutting and stitching while reducing both cost and regeneration risk

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Solution Approach 2:

The patent changes the physical and chemical parameters of scar tissue through topical application. The chemical formulation alters collagen fiber orientation, softens scar tissue consistency, and modifies the structural parameters of hypertrophic and keloid scars, achieving removal without surgery

Inventive Principle:
Principle #35Parameter changes

2Ease of manufacture

If topical chemical solutions are applied to scars, then the treatment is non-invasive and cost-effective, but existing formulations are ineffective for hypertrophic and keloid scars

Engineering Contradiction:
Improvetreatment accessibilityVSAvoidtreatment effectiveness
Core Design Contradiction:
Ease of manufactureVSReliability

Solution Approach 1:

The patent creates a composite chemical formulation combining three active ingredients: alpha-hydroxy acids (for collagen softening), beta-hydroxy acids (for keratolytic action), and 1,3-dihydroxybenzene (for collagen reorganization). This composite approach synergistically addresses the complex pathology of hypertrophic and keloid scars, achieving effectiveness where single-ingredient formulations failed

Inventive Principle:
Principle #40Composite materials

Solution Approach 2:

The patent enables self-service treatment through topical application. Users can apply the chemical solution themselves without requiring surgical intervention, making the treatment accessible, cost-effective, and eliminating the need for expensive medical procedures while maintaining reliability through the formulated chemical composition

Inventive Principle:
Principle #25Self-service

3Reliability

If microneedling is used to enhance penetration, then the chemical solution penetrates deeper into scar tissue, but additional treatment steps are required

Engineering Contradiction:
Improvechemical penetration depthVSAvoidtreatment procedure complexity
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The patent applies microneedling as a preliminary action before topical chemical application. The microneedling creates micro-channels in the scar tissue beforehand, allowing the subsequent chemical solution to penetrate deeper and more effectively. This sequential approach enhances treatment reliability while keeping the overall procedure manageable

Inventive Principle:
Principle #10Preliminary action

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The solution significantly softens and reorganizes scar tissue, improving its appearance by promoting orderly collagen distribution, reducing the scar's height, and minimizing regeneration risks, with noticeable results after a single treatment session and multiple sessions for optimal results.

Implementation Method 1

allowing at least the alcohol in the alcohol-based scar reduction chemical solution to evaporate

Methodology Applied
Scientific EffectEvaporation: Evaporation

Implementation Method 2

promoting collagen reorganization and uniformity with the surrounding skin

Methodology Applied
Scientific EffectDiffusion: Diffusion

Implementation Method 3

alpha-hydroxy acids, and beta-hydroxy acids is applied to the scar tissue, optionally enhanced by microneedling or dry needling to increase penetration, promoting collagen reorganization

Methodology Applied
Scientific EffectChemical Bonding: Chemical Bonding

Implementation Method 4

optionally enhanced by microneedling or dry needling to increase penetration

Methodology Applied
Scientific EffectPermeation: Permeation

Data Source

PatentUS10485755B1Formulation and method for treatment of non-acne scars
Publication Date: 2019.11.26 CHENG WADE
  • US10485755B1 patent drawing
  • US10485755B1 patent drawing
  • US10485755B1 patent drawing

AI summary

A chemical formula and method for treatment of non-acne skin scar tissue, in particular, hypertrophic and keloid scars. The chemical formula can comprise a topical chemical solution comprising alcohol, 1,3-dihydroxybenzene, alpha-hydroxy acids, and beta-hydroxy acids. This may be coated on the skin directly, or alternatively the surface of the skin scar can optionally be prepared by puncturing it with a plurality of small holes or micropunctures applied by microneedle or dry needle techniques, and the chemical solution can be applied by a brush or other method. Often a plurality of coatings, with intermediate air drying, may be required to deposit a sufficient amount of chemical during a treatment session. The scar area is then kept dry to help allow the chemical to penetrate, and the scar allowed to heal for about two weeks before any subsequent treatment. Experimental results showing the excellent efficacy of the formula and method are presented.